ORIGINAL PAPER <br> Preprocedural fibrinogen levels and MACE after percutaneous coronary intervention

Leszek Markuszewski; Marcin Makowski; Jacek Rysz; Konrad Masiarek; Robert Pietruszyński; Emilia Dobrowolska

eISSN: 1896-9151
ISSN: 1734-1922

Archives of Medical Science

Current issue Archive Special issues Abstracting and indexing Subscription

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

1/2006
vol. 2

Send email

Copy url:

abstract:

ORIGINAL PAPER
Preprocedural fibrinogen levels and MACE after percutaneous coronary intervention

Leszek Markuszewski

,

Marcin Makowski

,

Jacek Rysz

,

Konrad Masiarek

,

Robert Pietruszyński

,

Emilia Dobrowolska

Arch Med Sci 2006; 2, 1: 10-14

Online publish date: 2006/03/23

View full text Get citation

Introduction: Fibrinogen is a risk factor for cardiovascular disease and is related to the severity of coronary atherosclerosis. According to many studies elevated fibrinogen levels in patients with coronary angioplasty can be useful in predicting target vessel revascularization (TLR) and major adverse cardiac events (MACE). Material and methods: The studied group included 33 patients (10 – female and 23 males; mean age 62.9±8.9 years). The control group consisted of 30 persons (9 – females and 21 maels; mean age 61.8±9.8) who did not develop MACE during 12 months of follow-up. All patients were hospitalized from the beginning of 2003 to March of 2004 for acute coronary syndrome (ACS) and underwent percutaneous coronary intervention (PCI). Preprocedural concentrations of fibrinogen were measured in all patients. The aim of our study was to assess the preprocedural level of fibrinogen in patients developing MACE in comparison to patients from the study group. Results: We have not found statistically significant differences in the level of fibrinogen between the studied groups and the levels of fibrinogen persisted within the normal range of values. Conclusions: The level of fibrinogen within the normal limits can not define the group of patients after ACS who are at a high risk for developing MACE.

keywords:

ORIGINAL PAPER Preprocedural fibrinogen levels and MACE after percutaneous coronary intervention

Leszek Markuszewski , Marcin Makowski , Jacek Rysz , Konrad Masiarek , Robert Pietruszyński , Emilia Dobrowolska

MACE, restenosis, inflammation, fibrinogen

ORIGINAL PAPER
Preprocedural fibrinogen levels and MACE after percutaneous coronary intervention

Leszek Markuszewski

,

Marcin Makowski

,

Jacek Rysz

,

Konrad Masiarek

,

Robert Pietruszyński

,

Emilia Dobrowolska